Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for University of Minnesota Medical Center located at 2450 Riverside Ave, Minneapolis, MN, 55454 & includes data from NPIs 1679121024, 1407833643, 1255318523, 1013994359, 1316008212
Dexur analyzed Q4 2017 (October to December 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for University of Minnesota Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,007 | 1,934 | ||||||||||
| Surgical | 708 | 681 | ||||||||||
| Non Surgical | 1,299 | 1,253 | ||||||||||
| Cardiovascular | 298 | 288 | ||||||||||
| General Surgery | 249 | 231 | ||||||||||
| General Medicine | 249 | 235 | ||||||||||
| Gastroenterology & Endocrinology | 179 | 175 | ||||||||||
| Psychiatry & Mental Disorders | 176 | 170 | ||||||||||
| Urology | 171 | 165 | ||||||||||
| Orthopedics | 163 | 162 | ||||||||||
| Pulmonology | 157 | 151 | ||||||||||
| Oncology & Hematology | 127 | 124 | ||||||||||
| Neurology | 109 | 106 | ||||||||||
| Spine | 39 | 39 | ||||||||||
| Colorectal | 38 | 37 | ||||||||||
| Obstetrics & Gynecology | 30 | 29 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 15 | 15 |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Coronary Bypass |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
| DRG 027: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||
| DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | ||||||||||||
| Major Chest Procedures | ||||||||||||
| Pancreas, Liver And Shunt Procedures | ||||||||||||
| Other O.R. Procedures For Injuries | ||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| Other Digestive System O.R. Procedures |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 442: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Complications Of Treatment | ||||||||||||
| DRG 919: COMPLICATIONS OF TREATMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||
| DRG 439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 438: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
| Diabetes |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES | ||||||||||||
| Alcohol/Drug Abuse Or Dependence | ||||||||||||
| DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney Transplant | ||||||||||||
| DRG 652: KIDNEY TRANSPLANT | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Bladder Procedures | ||||||||||||
| Kidney And Ureter Procedures | ||||||||||||
| Kidney And Urinary Tract Infections |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Musculoskeletal System And Connective Tissue O.R. Procedures |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Respiratory System Diagnoses |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Red Blood Cell Disorders | ||||||||||||
| DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lymphoma And Non-Acute Leukemia |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||
| Other Disorders Of Nervous System |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Combined Anterior/Posterior Spinal Fusion |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Minnesota Total Hospitalizations (Oct 2017 to Dec 2017) | Minnesota Total Hospitalizations After Exclusion | Minnesota Total Users | Minnesota SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uterine And Adnexal Procedures For Malignancy |